Publications by authors named "Christopher Brittain"

Claim this Profile
T
Targeting IL-6 Receptor Signaling with Satralizumab in Thyroid Eye Disease: Design of the Phase 3 SatraGO-1 and SatraGO-2 Trials.
Daniel Ezra, Atif Collins, Zdenka Haskova, Thomas Kuenzel, Hiroaki Ida, Christopher Brittain

Ophthalmol Ther· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Port Delivery System With Ranibizumab vs Monitoring in Nonproliferative Diabetic Retinopathy Without Macular Edema: The Pavilion Randomized Clinical Trial.
Dante J Pieramici, Carl C Awh, Margaret Chang, Andres Emanuelli, Nancy M Holekamp, Christopher Brittain

JAMA Ophthalmol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Innovations through crop switching happen on the diverse margins of US agriculture.
Matthew M Kling, Christopher T Brittain, Gillian L Galford, Timothy M Waring, Laurent Hébert-Dufresne

Proc Natl Acad Sci U S A· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Faricimab for Macular Edema due to Retinal Vein Occlusion: 24-Week Results from the BALATON and COMINO Trials.
Ramin Tadayoni, Liliana P Paris, Carl J Danzig, Francis Abreu, Arshad M Khanani, Christopher Brittain

Ophthalmology· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intraocular Pressure Outcomes After Lampalizumab Injections in Patients With Geographic Atrophy.
Neil M Bressler, K Bailey Freund, Sophie J Bakri, Judy E Kim, Daniela Ferrara, Christopher Brittain

JAMA Ophthalmol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Archway Randomized Phase 3 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration.
Nancy M Holekamp, Peter A Campochiaro, Margaret A Chang, Daniel Miller, Dante Pieramici, Christopher Brittain

Ophthalmology· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials.
Jeffrey S Heier, Arshad M Khanani, Carlos Quezada Ruiz, Karen Basu, Philip J Ferrone, Christopher Brittain

Lancet· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Building on the success of anti-vascular endothelial growth factor therapy: a vision for the next decade.
Anthony P Adamis, Christopher J Brittain, Atul Dandekar, J Jill Hopkins

Eye (Lond)· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Progression from Early/Intermediate to Advanced Forms of Age-Related Macular Degeneration in a Large UK Cohort: Rates and Risk Factors.
Usha Chakravarthy, Clare C Bailey, Peter H Scanlon, Martin McKibbin, Rehna S Khan, Christopher J Brittain

Ophthalmol Retina· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Direct Ophthalmic Healthcare Resource Use among Patients with Geographic Atrophy in a Large Cohort from the United Kingdom.
Usha Chakravarthy, Clare C Bailey, Peter H Scanlon, Martin McKibbin, Rehna S Khan, Christopher J Brittain

Ophthalmol Retina· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterizing Disease Burden and Progression of Geographic Atrophy Secondary to Age-Related Macular Degeneration.
Usha Chakravarthy, Clare C Bailey, Robert L Johnston, Martin McKibbin, Rehna S Khan, Christopher J Brittain

Ophthalmology· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Lampalizumab for Geographic Atrophy Due to Age-Related Macular Degeneration: Chroma and Spectri Phase 3 Randomized Clinical Trials.
Frank G Holz, Srinivas R Sadda, Brandon Busbee, Emily Y Chew, Paul Mitchell, Christopher Brittain

JAMA Ophthalmol· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Progression of Geographic Atrophy Secondary to Age-Related Macular Degeneration.
Monika Fleckenstein, Paul Mitchell, K Bailey Freund, SriniVas Sadda, Frank G Holz, Christopher Brittain

Ophthalmology· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
THE PATHOPHYSIOLOGY OF GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION AND THE COMPLEMENT PATHWAY AS A THERAPEUTIC TARGET.
David S Boyer, Ursula Schmidt-Erfurth, Menno van Lookeren Campagne, Erin C Henry, Christopher Brittain

Retina· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CLINICAL ENDPOINTS FOR THE STUDY OF GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION.
SriniVas R Sadda, Usha Chakravarthy, David G Birch, Giovanni Staurenghi, Erin C Henry, Christopher Brittain

Retina· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Ranibizumab 0.5 mg for Diabetic Macular Edema with Bimonthly Monitoring after a Phase of Initial Treatment: 18-Month, Multicenter, Phase IIIB RELIGHT Study.
Ian Pearce, Sanjiv Banerjee, Ben J L Burton, Usha Chakravarthy, Louise Downey, Christopher Brittain

Ophthalmology· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Ranibizumab in myopic choroidal neovascularization: the 12-month results from the REPAIR study.
Adnan Tufail, Nirodhini Narendran, Praveen J Patel, Sobha Sivaprasad, Winfried Amoaku, Christopher Brittain

Ophthalmology· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in scanning laser polarimetry before and after laser capsulotomy for posterior capsular opacification.
Christopher J Brittain, Kenneth C S Fong, Christopher C Hull, Ian H Gillespie

J Glaucoma· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective comparative switch study from timolol 0.5% and latanoprost 0.005% to bimatoprost 0.03%.
Christopher J Brittain, Rohit Saxena, Andrew Waldock

Adv Ther· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis